Related content

Romiplostim as early treatment for refractory primary immune thrombocytopenia

By Contis Anne   Lazaro Estibaliz   Greib Carine   Pellegrin Jean-Luc   Viallard Jean-François  

International Journal of Hematology, Vol. 98, Iss. 5, 2013-11 ,pp. : 520-524

Springer Publishing Company

Access to resources Recommend Favorite

Immune thrombocytopenia

By Provan Drew  

Hematology, Vol. 18, Iss. 4, 2013-07 ,pp. : 242-243

Maney Publishing

Access to resources Recommend Favorite

Erratum to: Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region

By Lee Lai   Caguioa Priscilla   Chin Ng   Chiou Tzeon-Jye   Lee Jong   Miyakawa Yoshitaka   Tambunan Karmel   Chong Beng  

International Journal of Hematology, Vol. 98, Iss. 6, 2013-12 ,pp. : 729-729

Springer Publishing Company

Access to resources Recommend Favorite

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

By Michel Marc   te Boekhorst PeterA W   Janssens Ann   Pabinger-Fasching Ingrid   Sanz MiguelA   Nie Kun   Kreuzbauer Georg  

Hematology, Vol. 16, Iss. 5, 2011-09 ,pp. : 274-277

Maney Publishing

Access to resources Recommend Favorite

Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes

By Townsley Danielle   Desmond Ronan   Dunbar Cynthia   Young Neal  

International Journal of Hematology, Vol. 98, Iss. 1, 2013-07 ,pp. : 48-55

Springer Publishing Company

Access to resources Recommend Favorite